176 related articles for article (PubMed ID: 37357180)
21. Creutzfeldt-Jakob disease surveillance in Australia: update to December 2016.
Klug GM; Sarros S; Stehmann C; Simpson M; McLean C; Masters CL; Collins SJ
Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30626302
[TBL] [Abstract][Full Text] [Related]
22. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
[TBL] [Abstract][Full Text] [Related]
23. Prion diseases with a focus on Creutzfeldt-Jakob disease, a summary of the incidence of Creutzfeldt-Jakob disease in the Czech Republic over the last 17 years, 2000-2017.
Kolářová K; Marešová M; Manďáková Z; Kynčl J
Epidemiol Mikrobiol Imunol; 2018; 67(4):155-160. PubMed ID: 30630318
[TBL] [Abstract][Full Text] [Related]
24. Human Prion Disease Surveillance in Washington State, 2006-2017.
Sánchez-González L; Maddox RA; Lewis LC; Blevins JE; Harker EJ; Appleby BS; Person MK; Schonberger LB; Belay ED; DeBolt C; Lofy KH
JAMA Netw Open; 2020 Oct; 3(10):e2020690. PubMed ID: 33064135
[TBL] [Abstract][Full Text] [Related]
25. Prion disease in Indigenous Australians.
Panegyres PK; Stehmann C; Klug GM; Masters CL; Collins S
Intern Med J; 2021 Jul; 51(7):1101-1105. PubMed ID: 32237029
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program.
Lim JS; Kwon HM; Jang JW; Ju YR; Kim S; Park YH; Park SY; Kim S
Prion; 2015; 9(2):136-43. PubMed ID: 25996401
[TBL] [Abstract][Full Text] [Related]
27. Creutzfeldt-Jakob disease: Australian surveillance update to March 2007.
Klug GM; Boyd A; Lewis V; Douglass SL; Roberts H; Argent R; Masters CL; Collins SJ
Commun Dis Intell Q Rep; 2007 Jun; 31(2):194-7. PubMed ID: 17724994
[TBL] [Abstract][Full Text] [Related]
28. Prospective 25-year surveillance of prion diseases in France, 1992 to 2016: a slow waning of epidemics and an increase in observed sporadic forms.
Denouel A; Brandel JP; Peckeu-Abboud L; Seilhean D; Bouaziz-Amar E; Quadrio I; Oudart JB; Lehmann S; Bellecave P; Laplanche JL; Haik S
Euro Surveill; 2023 Dec; 28(50):. PubMed ID: 38099349
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease.
Llorens F; Villar-Piqué A; Hermann P; Schmitz M; Calero O; Stehmann C; Sarros S; Moda F; Ferrer I; Poleggi A; Pocchiari M; Catania M; Klotz S; O'Regan C; Brett F; Heffernan J; Ladogana A; Collins SJ; Calero M; Kovacs GG; Zerr I
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32059611
[TBL] [Abstract][Full Text] [Related]
30. Prospective 10-year surveillance of human prion diseases in Japan.
Nozaki I; Hamaguchi T; Sanjo N; Noguchi-Shinohara M; Sakai K; Nakamura Y; Sato T; Kitamoto T; Mizusawa H; Moriwaka F; Shiga Y; Kuroiwa Y; Nishizawa M; Kuzuhara S; Inuzuka T; Takeda M; Kuroda S; Abe K; Murai H; Murayama S; Tateishi J; Takumi I; Shirabe S; Harada M; Sadakane A; Yamada M
Brain; 2010 Oct; 133(10):3043-57. PubMed ID: 20855418
[TBL] [Abstract][Full Text] [Related]
31. [Epidemiological surveillance of Creutzfeldt-Jakob in France].
Brandel JP; Salomon D; Capek I; Vaillant V; Alpérovitch A
Rev Neurol (Paris); 2009; 165(8-9):684-93. PubMed ID: 19467685
[TBL] [Abstract][Full Text] [Related]
32. Rapid amplification of prions from variant Creutzfeldt-Jakob disease cerebrospinal fluid.
Barria MA; Lee A; Green AJ; Knight R; Head MW
J Pathol Clin Res; 2018 Apr; 4(2):86-92. PubMed ID: 29665324
[TBL] [Abstract][Full Text] [Related]
33. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
Bonda DJ; Manjila S; Mehndiratta P; Khan F; Miller BR; Onwuzulike K; Puoti G; Cohen ML; Schonberger LB; Cali I
Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
[TBL] [Abstract][Full Text] [Related]
34. [Prion diseases or transmissible spongiform encephalopathies].
Brandel JP
Rev Med Interne; 2022 Feb; 43(2):106-115. PubMed ID: 34148672
[TBL] [Abstract][Full Text] [Related]
35. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part I].
Zaborowski A
Psychiatr Pol; 2004; 38(2):283-96. PubMed ID: 15307293
[TBL] [Abstract][Full Text] [Related]
36. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.
Brandel JP; Peckeu L; Haïk S
Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616
[TBL] [Abstract][Full Text] [Related]
37. Genetic Prion Disease: Insight from the Features and Experience of China National Surveillance for Creutzfeldt-Jakob Disease.
Shi Q; Chen C; Xiao K; Zhou W; Gao LP; Chen DD; Wu YZ; Wang Y; Hu C; Gao C; Dong XP
Neurosci Bull; 2021 Nov; 37(11):1570-1582. PubMed ID: 34487324
[TBL] [Abstract][Full Text] [Related]
38. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.
Ladogana A; Puopolo M; Croes EA; Budka H; Jarius C; Collins S; Klug GM; Sutcliffe T; Giulivi A; Alperovitch A; Delasnerie-Laupretre N; Brandel JP; Poser S; Kretzschmar H; Rietveld I; Mitrova E; Cuesta Jde P; Martinez-Martin P; Glatzel M; Aguzzi A; Knight R; Ward H; Pocchiari M; van Duijn CM; Will RG; Zerr I
Neurology; 2005 May; 64(9):1586-91. PubMed ID: 15883321
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis of prion diseases].
Federspil PA; Federspil P; Plinkert PK
HNO; 2002 Apr; 50(4):327-31. PubMed ID: 12063690
[TBL] [Abstract][Full Text] [Related]
40. Review: Laboratory diagnosis and surveillance of Creutzfeldt-Jakob disease.
Lee J; Hyeon JW; Kim SY; Hwang KJ; Ju YR; Ryou C
J Med Virol; 2015 Jan; 87(1):175-86. PubMed ID: 24978677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
